We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.19%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$24B
AUM Growth
-$8.57B
(-26%)
Cap. Flow
-$8.5B
Cap. Flow
% of AUM
-35.37%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
5,150
New
660
Increased
1,270
Reduced
2,242
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Amazon
AMZN
|
+$264M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$138M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Doximity
DOCS
|
+$72.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
| 2 |
Intuitive Surgical
ISRG
|
+$110M |
| 3 |
Boston Scientific
BSX
|
+$96.4M |
| 4 |
Cummins
CMI
|
+$90.4M |
| 5 |
Microsoft
MSFT
|
+$77.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.1% |
| 2 | Consumer Discretionary | 7.52% |
| 3 | Industrials | 5.58% |
| 4 | Financials | 4.45% |
| 5 | Healthcare | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
CALL
Genuine Parts
GPC
$17.1B
| $687K | ﹤0.01% |
6,500
-1,700
| -21% | -$210K |
|
2352
PUT
Ezcorp Inc
EZPW
$1.82B
| $685K | ﹤0.01% |
+27,000
| New | +$647K |
|
2353
PUT
Veeva Systems
VEEV
$30.3B
| $685K | ﹤0.01% |
3,900
-3,300
| -46% | -$648K |
|
2354
CALL
Ultragenyx Pharmaceutical
RARE
$2.65B
| $685K | ﹤0.01% |
32,700
-5,600
| -15% | -$126K |
|
2355
PUT
Viking Holdings
VIK
$44.9B
| $683K | ﹤0.01% |
9,300
-4,300
| -32% | -$314K |
|
2356
PUT
SM Energy
SM
$7.96B
| $683K | ﹤0.01% |
21,900
-102,500
| -82% | -$2.34M |
|
2357
CALL
Birkenstock
BIRK
$7.47B
| $681K | ﹤0.01% |
19,000
-11,000
| -37% | -$429K |
|
2358
PUT
Madrigal Pharmaceuticals
MDGL
$12.6B
| $681K | ﹤0.01% |
1,300
+700
| +117% | +$334K |
|
|
SA
2359
PUT
Seabridge Gold
SA
$2.8B
| $677K | ﹤0.01% |
23,900
-92,400
| -79% | -$2.95M |
|
2360
XPeng
XPEV
$11.8B
| $677K | ﹤0.01% |
39,539
-78,623
| -67% | -$1.46M |
|
2361
Caesars Entertainment
CZR
$6.1B
| $676K | ﹤0.01% |
+25,559
| New | +$608K |
|
2362
CALL
Bitdeer Technologies
BTDR
$2.81B
| $675K | ﹤0.01% |
78,000
-211,900
| -73% | -$2.23M |
|
2363
PUT
Cheesecake Factory
CAKE
$4.21B
| $673K | ﹤0.01% |
12,300
-29,100
| -70% | -$1.73M |
|
2364
CALL
Globant
GLOB
$1.35B
| $673K | ﹤0.01% |
14,600
+9,600
| +192% | +$531K |
|
2365
VeriSign
VRSN
$25.3B
| $673K | ﹤0.01% |
2,710
-81,526
| -97% | -$19.4M |
|
2366
PUT
Cytokinetics
CYTK
$11B
| $672K | ﹤0.01% |
10,200
-7,400
| -42% | -$470K |
|
|
DFTX
2367
Definium Therapeutics
DFTX
$5.73B
| $671K | ﹤0.01% |
+35,485
| New | +$602K |
|
2368
MetLife
MET
$61B
| $670K | ﹤0.01% |
9,476
+4,421
| +87% | +$331K |
|
2369
Franco-Nevada
FNV
$41.4B
| $670K | ﹤0.01% |
2,711
-4,567
| -63% | -$1.13M |
|
2370
Sturm, Ruger & Co
RGR
$610M
| $669K | ﹤0.01% |
16,698
+16,408
| +5,658% | +$623K |
|
2371
Teladoc Health
TDOC
$1.58B
| $669K | ﹤0.01% |
+122,690
| New | +$688K |
|
2372
Kimberly-Clark
KMB
$36.4B
| $666K | ﹤0.01% |
6,905
-24,505
| -78% | -$2.51M |
|
2373
CALL
KeyCorp
KEY
$24.3B
| $664K | ﹤0.01% |
33,100
+19,100
| +136% | +$400K |
|
2374
Mohawk Industries
MHK
$6.9B
| $663K | ﹤0.01% |
+6,738
| New | +$785K |
|
2375
SharkNinja
SN
$21B
| $659K | ﹤0.01% |
6,225
-9,213
| -60% | -$1.08M |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Walleye Capital held 5,150 positions worth $24B, down 26% from $32.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Walleye Capital withdrew a net $8.5B in Q1 2026, closing 835 positions and reducing 2,242 holdings. Its most notable exit was Repligen, an estimated $68.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 7.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Walleye Capital opened a new position in Texas Roadhouse worth $51.4M.
- Walleye Capital's largest Q1 2026 buy was Texas Roadhouse: 311,416 shares worth $51.4M.
- Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $948M increase.
- Walleye Capital's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $778M.
- Walleye Capital fully exited Repligen in Q1 2026, selling an estimated $68.3M.
- Walleye Capital's ten largest holdings make up 33% of its $24B portfolio in Q1 2026.
- Walleye Capital opened 660 new positions and closed 835 in Q1 2026.
- Walleye Capital's portfolio value fell 26% quarter-over-quarter to $24B.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.